BMRD-001

N/A

Report date: 2023/08/17 17:51:48
NME

Base Information

Drug NameBMRD-001
Drug Alias NameBMRD-001
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionIduronate-2-sulfatase replacements
TargetsIduronate-2-sulfatase
Therapy Area/IndicationsMucopolysaccharidosis II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiorchestra Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBiorchestra Co Ltd
Inactive CompaniesN/A
Active IndicationsMucopolysaccharidosis II
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A